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Intra-thoracic desmoid tumors are exceedingly rare tumors in the pediatric population, and can present
with compression of cardiopulmonary structures and respiratory compromise. Surgical and anesthetic
management of these tumors are challenging. We report the case of a 14-year-old male who presented
with dyspnea, found to have a large intra-thoracic mass that was critically compressing his trachea. We
provide a review of the literature of desmoid tumors and discuss the management of intra-thoracic
masses.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Case report
A previously healthy 14-year-old male began experiencing
slowly progressive respiratory symptoms two months prior to
presentation to care. His previous medical problems included only
mild intermittent asthma, for which he occasionally used an
inhaler. His family medical history was signiﬁcant only for diabetes.
Initially, he began to notice mild dyspnea on exertion and fatigue.
During this time, his parents also noted a 14-pound weight loss.
One week prior to presentation, while swimming in a lake, he
experienced signiﬁcant dyspnea.
He presented to an outside hospital’s urgent care clinic, where
a chest radiograph (Fig. 1) demonstrated a large right chest opa-
ciﬁcation with mass-effect and leftward shift of the heart and
mediastinum, and was immediately admitted to the pediatric
intensive care unit (PICU). A contrast enhanced CT scan of the
thorax (Fig. 2) revealed a large, homogeneously enhancing right-
sided intra-thoracic mass, which crossed 6 cm to the left of
midline and compressed the right atrium of the heart. There were
no large calciﬁcations or macroscopic fat density identiﬁed withinInc. This is an open access article uthe mass. The cross section of his trachea was measured to be
12 mm  4 mm just superior to the carina. There was cortical ir-
regularity and spiculation noted in the ﬁrst and second right ribs,
suggesting rib invasion by the soft tissue mass or point of origin
from the rib of the soft tissue mass. There was aerated lung at the
right base. The imaging differential diagnoses included: medias-
tinal origin lymphoma or malignant germ cell tumor; pulmonary
and chest wall origin carcinoid tumor and Askin tumor; and
metastatic disease [1].
He had a bedside core needle biopsy under procedural anes-
thesia of versed, ketamine and dexmedetomidine. He became
cyanotic and desaturated, requiring bag-mask ventilation and
epinephrine. Subsequently, he was tachycardic with a hyper-
dynamic precordium. The head of his bed was raised upright, and
he was given normal saline and methylprednisolone, with resolu-
tion of his tachycardia. An arterial line was placed for continuous
monitoring of his blood pressure. A bedside echocardiogram
showed signiﬁcant leftward deviation of the heart and aorta with
impaired right atrial ﬁlling, but a normal ejection fraction. Pre-
liminary pathology from the core needle biopsy showed low-grade
spindle-cell neoplasm.
He was transferred to our hospital in stable condition. He
showed no clinical evidence of superior vena cava syndrome. At this
time, he did not exhibit any shortness of breath at rest, and was ablender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Radiographs on initial presentation demonstrate a large mass-like opaciﬁcation of the right chest with leftward shift of the heart and mediastinum including the trachea.
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different from one week prior, sounding more raspy and requiring
increased effort to speak. Beta human choriogonadotropin, alpha
fetoprotein, and urine catecholamines were all within normal
limits. Ultrasound examinations of his testes and abdomen were
negative for any masses. A second echocardiogram showed signif-
icant compression of both atria.
A care coordination conference was held with oncology, general
surgery, radiation oncology and intensive care teams. Pre-operative
endovascular embolization of the tumor was not planned. Neo-
adjuvant use of radiotherapy and chemotherapy were discussed.
However, the consensus decision was to proceed with primary
surgical resection of the mass, due to the patient’s tenuous respi-
ratory status as evidenced by the episode of desaturation and sig-
niﬁcant dyspnea at the transferring hospital. CT imaging
demonstrated a tracheal cross sectional area of 0.48 cm2, which is
32% of expected for our patient’s age and gender. Evidence suggests
that for pediatric patients with mediastinal tumors, compression ofFig. 2. CT scan demonstrating a large enhancing soft tissue mass occupying the right ches
superior to the carina (green arrow).the trachea to cross sectional areas of less than 50% is extremely
high risk for total respiratory collapse upon induction of general
anesthesia [2]. The goals of surgery were primary relief of
compression of mediastinal structures and pathological deﬁnition
of the tumor. The most serious risks during surgery were antici-
pated to be induction of anesthesia because of the compressed
proximal airway, and the likelihood for substantial bleeding from
the large tumor. The family was counseled about the risks and
beneﬁts of surgery, and decided to proceed.
The operative team included two pediatric general surgeons, a
pediatric cardiac surgeon, a general surgery resident and the pe-
diatric cardiac anesthesia team. In case of cardiorespiratory
collapse on induction of anesthesia, the team planned for rapid
decompression of the chest through median sternotomy, and
central cannulation for cardiopulmonary bypass. Additionally,
femoral venous and arterial catheters were placed preoperatively
in preparation for emergent extracorporeal membrane
oxygenation.t and crossing the midline. There is mass effect and compression on the trachea just
Fig. 3. The ﬁrst of several large pieces of tumor removed from the chest.
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midazolam sedation. Topical lidocaine was sprayed onto the poste-
rior oropharynx and vocal cords prior to intubation. The patient
maintained his oxygen saturation and stroke volume through in-
duction. The incision was a median sternotomy with right thora-
cotomy for maximum exposure. After the sternotomy, there was an
immediate improvement in ventilation and the patient was then
fully paralyzed. The right pleura was divided, with immediate
visualization of the mass ﬁlling the entire right chest. The mass was
dissected from the surrounding tissues using a combination of blunt
dissection and electrocautery. Effort was made to remove the mass
en block, but it proved too difﬁcult to do so because of its large size
and the need to control bleeding. Ultimately, themass was removed
in multiple pieces. The mass was safely freed from the pericardium
and vena cavamedially, the diaphragm inferiorly, and the upper lobe
of the right lungmedially. Althoughnomajor vesselswere damaged,
the tumor itself was very bloody, requiring many surgical clips and
use of an argonbeamcoagulator. Themass remained adherent to the
apex of the right chest and could not be safely separated from the
area of the subclavian vessels and the brachial plexus. As much tu-
mor as possible was removed, ultimately leaving a rim of residual
tumor approximately 5e10mm thick. The areawas coagulatedwith
the argon beam and absorbable hemostatic cellulose strips. This
surface was marked with six large vessel clips.
There were no operative complications, and the patient toler-
ated the procedure well. Intraoperative blood loss was estimated at
7 L, primarily from the tumor itself. The patient was transfused 21
units packed units of red blood cells, 18 units of fresh frozen plasma,
and 4 units of platelets. The patient was transferred to the PICU
intubated. He was hypotensive postoperatively, but was resusci-
tated with crystalloid.
His postoperative course was relatively uncomplicated. He was
extubated without issue two days after his operation. He was dis-
charged six days after his operation. Final pathology of the surgical
specimen was desmoid type ﬁbromatosis. The tumor measured
31.0  23.5  11.2 cm and weighed 2.93 kg (Fig. 3).
He continued to recover well at home. He had no residual
symptoms from debulking surgery and demonstrated no injury to
his brachial plexus. He was followed by pediatric oncology and
started on oral sorafenib in an attempt to shrink the residual tumor.
An oral agent was chosen over intravenous chemotherapy to facili-
tatehis return to school andnormal activities. Radiation therapywas
not recommended because of his young age. He was evaluated by
genetics and found to be negative for the APC gene mutation.
2. Discussion
Desmoid tumors, also called aggressive ﬁbromatosis, are benign
soft tissue tumors arising from musculoaponeurotic or fascial
structures. Although they have no potential for metastasis, they are
known to be very locally aggressive, and can invade or compress
neighboring structures. Additionally, they have high rates of local
recurrence, even with complete surgical resection with negative
margins. They most commonly affect individuals aged 15e60, and
are slightly more common in women than men. Desmoids are rare
tumors, comprising approximately 0.03% of all neoplasms and 3% of
soft tissue tumors. Approximately two-thirds of all desmoid tumors
are intra-abdominal [3]. Tumors affecting the chest wall comprise
roughly 20% of all extra-abdominal desmoids, which also occur in
the abdominal wall, retroperitoneum, hip or buttock, neck, or ex-
tremities [3,4]. Desmoid tumors have a variable clinical course, and
include lesions that demonstrate spontaneous regression, long-
term stability, slow growth or rapid progression.
The pathogenesis of desmoid tumors is not completely under-
stood, though is likely related to defects in connective tissue.Genetic predisposition, hormonal effects and physical trauma are
related to the development of desmoid tumors [4e6]. The majority
of desmoid tumors are sporadic. Around 7.5% of all lesions are
associated with Familial Adenomatous Polyposis (FAP) [7]. FAP-
associated desmoids result from mutations in the adenomatous
polyposis coli (APC) gene, whereas sporadic tumors are caused by
mutations in either APC or beta-catenin [4,6]. Desmoid tumors have
been associated with high estrogen states, especially pregnancy
[6,8]. Approximately 30% of patients with desmoid tumors have a
history of physical trauma, most commonly prior surgery [6,9].
Intra-thoracic desmoid tumors are exceedingly rare; approxi-
mately 40 case reports have been published [10], with around 10 of
these found in pediatric patients. Intra-thoracic tumors originate
from the chest wall structures such as the intercostal muscles or
shoulder girdle and grow inward, or can originate frommediastinal
structures. Intra-thoracic desmoid tumors are typically clinically
silent until they are discovered incidentally or until they begin to
compromise nearby structures. In a recent series of 28 intra-thoracic
tumors, 86% presented with palpable lesions, 71% with pain, 25%
with loss ofmotor function, and 7%with hypoesthesia. A total of 11%
were asymptomatic and identiﬁed incidentally [4]. Very fewcases of
intra-thoracic desmoid tumor presentedwith respiratory symptoms
[10,11], similar to our case. Even very large intra-thoracic desmoids
have presented with no respiratory symptoms [12,13]. The largest
tumor removed from the thorax weighed 5.89 kg [10].
The overall mortality from desmoid tumors is roughly 1% or less,
due to their inability to metastasize. Fatalities result from me-
chanical compression or invasion of neighboring vital structures
[6]. Consequently, the mortality rate is higher in intra-abdominal
and intra-thoracic cases. The goal of care in treating desmoid tu-
mors is reduction of mechanical compression and invasion of
neighboring structures. The primary treatment for desmoid tumors
is surgical resection, and the measure of treatment success is
recurrence-free survival.
There are numerous studies reporting risk factors for desmoid
tumor recurrence. In amultivariate analysis 495 patients, the largest
cohort of desmoid tumors treated with surgery, only tumor site,
tumor size andpatient agewereassociatedwith recurrence rate [14].
Using a prognostic nomogram published with this study, our pa-
tient’s 5-year local recurrence-free survival rate is approximately
0.3. Theeffectofmicroscopicallypositive surgicalmargins is unclear;
someseries report ahigher recurrence rate than in tumorswithwide
negativemargins [6,15,16], while others claim that recurrence rate is
independent of microscopic margin status [6,17]. In most studies,
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higher recurrence rate than surgically freemargins,withup to89%of
tumors recurring [17,18]. However, even tumors that are surgically
resectedwith negativemargins can have recurrence rates of 16e19%
[6,15e18]. Other reported risk factors associated with recurrence
include anatomic site, size, genderandage [6]. Tumors that affect the
extremities have the worst prognosis, followed by intra-abdominal
or extra-abdominal tumors. Those affecting the abdominalwall have
the lowest rate of recurrence. Tumors greater than 7 cm have higher
rates of recurrence. Some studies have reported that tumors
affecting women and those affecting younger individuals have
higher rates of recurrence [6]. There is preliminary evidence that
recurrence rate may be correlated with certain molecular factors, a
topic of current research interest.
Historically, desmoids have been thought to be poor candidates
for systemic therapy due to their slow growth, low cellularity and
typical high differentiation. However, evidence from several retro-
spective case series suggests that adjuvant treatment modalities
may have efﬁcacy in the primary treatment of desmoid tumors and
in prevention of recurrence. Radiation therapy has been suggested
to be beneﬁcial in preventing recurrence, or for treatment of
unresectable tumors [17,19,20], although some have found no
added beneﬁt of radiation [21]. There is limited evidence for the use
of systemic therapy, though the use of nonsteroidal anti-inﬂam-
matory [18], selective estrogen receptor modulation [4], and cyto-
toxic [17] agents have been proposed. There is a need for a
multicenter trial to establish the efﬁcacy of adjuvant therapies [17].
In our case, the tumor was clinically silent until it grew large
enough to begin compressing the mediastinum, reducing cardiac
output and constricting the trachea. This presented several chal-
lenges to the treatment team. The ﬁrst challenge was the danger of
general anesthesia with a greatly compressed mediastinum. There
have been several algorithms proposed for the management of
mediastinal masses in children [2,22]. An important pre-operative
evaluation is tracheal cross sectional area, calculated using a CT
image. Evidence suggests that tracheal cross sectional area less than
50% of expected for age and gender have a high risk for total res-
piratory collapse upon induction of general anesthesia [2,23]. In our
case, the distal trachea was reduced to a cross sectional area of
0.48 cm2 above the carina, just 32% of normal [24]. Thus, prior to the
operation, our patient’s femoral artery and veinwere cannulated for
the possible need for extracorporeal membrane oxygenation.
Additionally, a pediatric cardiac surgeon was ready to provide
central cannulation if necessary. Fortunately, our patient tolerated
induction well, and never demonstrated evidence of impending
respiratory collapse.
A second surgical challengewas the large size of themass, which
weighed nearly 3 kg and measured over 30 cm long. Even using a
full sternotomy and thoracotomy, en bloc extrication of the mass
would not have been feasible without the resection of several ribs.
Thus, we elected to remove the mass in pieces. Desmoid tumors are
not known to be particularly vascular, and bleeding was easy to
control by use of surgical clips and the argon beam coagulator. In
addition, desmoids do not metastasize, and so could not seed the
thorax or disseminate systemically. In biopsy-proven desmoid
tumors, we consider resection in multiple pieces to be an appro-
priate surgical method.
A third surgical challengewas the fact that theorigin of the tumor
was strongly adherent to the apex of the right chest. Full primary
resection of the tumorwould have required deep dissection near the
subclavian artery and vein and the brachial plexus. Thus, a small cap
of residual tumor was left and marked with surgical clips. Adjuvant
radiation and systemic therapy may help this tumor to regress.
However, further surgical intervention will likely be required.3. Conclusion
Desmoid tumors are locally aggressive and can become life
threatening when they compress neighboring structures. Intra-
thoracic tumors are very rare, and do not usually present primarily
with respiratory symptoms. Special precautions must be taken
when managing patients with a tumor compressing the medias-
tinum. Desmoid tumors have high rates of recurrence evenwith full
surgical resection. Further research is needed to optimize adjuvant
treatments of desmoid tumors.References
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